Advertisement
News
Subscribe to MDT Magazine News

Endosense Secures USD 40.3 Million/CHF 37.4 Million Series C Financing

November 27, 2012 7:00 am | by The Associated Press | Comments

GENEVA--(BUSINESS WIRE)--Nov 27, 2012--Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has announced the close of a USD 40.3 million/CHF 37.4 million series C financing. Led by...

CardioDx Announces Participation in Landmark NHLBI Trial of Strategies for Assessment of Stable Patients With Symptoms of Coronary Artery Disease

November 27, 2012 7:00 am | by The Associated Press | Comments

PALO ALTO, Calif.--(BUSINESS WIRE)--Nov 27, 2012--CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced participation in the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE), the first large randomized trial using clinical...

TriReme Announces a New Round of Financing Totalling US$18 Million

November 27, 2012 6:28 am | by Bio-Medicine.Org | Comments

PLEASANTON, Calif., Nov. 27, 2012 /- TriReme Medical, Inc. and its affiliates (TriReme) announced today a new round of financing that brings a total of US$18 million into the group. The round is led by Luminor Capital of Singapore and includes major existing investors and new Asian investors. TriReme provides a range of innovative solutions for complex lesions and proceeds of the ne...

Advertisement

Research and Markets: Netherlands Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

November 27, 2012 5:59 am | by The Associated Press | Comments

DUBLIN--(BUSINESS WIRE)--Nov 27, 2012--Research and Markets ( http://www.researchandmarkets.com/research/zmc3mb/netherlands ) has announced the addition of GlobalData's new report "Netherlands Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip...

Research and Markets: Russian Federation Orthopedic Devices Market Outlook to 2018

November 27, 2012 5:31 am | by The Associated Press | Comments

DUBLIN--(BUSINESS WIRE)--Nov 27, 2012--Research and Markets ( http://www.researchandmarkets.com/research/f93w66/russian ) has announced the addition of GlobalData's new report "Russian Federation Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip...

Trovagene and Barretos Cancer Hospital, Brazil, to Evaluate Urine-Based HPV Assay as Potential Pap Smear Replacement

November 27, 2012 5:27 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Calif., Nov. 27, 2012 /- Trovagene, Inc. (NASDAQ:  TROV) and the PIO XII Foundation, affiliated with Brazil's Barretos Cancer Hospital, today announced that they entered into a research collaboration to evaluate the performance of a urine-based molecular assay for detection of HPV types associated with cervical lesions. The goal of the study is to determine whet...

Mazor Robotics Announces Financial Results for the Third Quarter 2012 and Provides Update on Operating Progress

November 27, 2012 4:30 am | by The Associated Press | Comments

CAESAREA, Israel--(BUSINESS WIRE)--Nov 27, 2012--Mazor Robotics Ltd. (TASE: MZOR), a developer of innovative surgical robots and complementary products, today filed its financial statements with the Tel Aviv Stock Exchange for the third quarter ended September 30, 2012. The company also provided...

Toshiba’s MR Enhancements Improve Efficiency, Patient Care

November 27, 2012 3:00 am | by The Associated Press | Comments

CHICAGO--(BUSINESS WIRE)--Nov 27, 2012--RSNA Booth #3438, South Hall - To make MR imaging more user and patient friendly, Toshiba America Medical Systems, Inc. unveiled enhancements to its Vantage Titan™ MR product line at this year’s Radiological Society of North America (RSNA) annual meeting in...

Advertisement

CeQur’s insulin delivery device approved in Europe

November 27, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | Comments

CeQur Corp., which has its U.S. headquarters in Marlborough, has received CE Mark approval for its lead product, which provides three days of consistent delivery of insulin to people with type 2 diabetes.

Samsung Medison Showcases New Medical Equipment and Technology with Samsung Electronics at RSNA 2012

November 26, 2012 10:14 pm | by The Associated Press | Comments

Samsung Medison, a leading global medical devices company, announced that it participated the "RSNA (Radiological Society of North America) 2012", held in McCormick Place, Chicago from November 25th to 30th, in the biggest scale thus far. This is the first show in the U.S. highlighting a full...

MetroStar Home Health Products Holds Sandy Relief Holiday Toy Drive

November 26, 2012 2:51 pm | by Bio-Medicine.Org | Comments

BROOKLYN, N.Y., Nov. 26, 2012 /- In continuing their efforts to assist New Yorkers return to normalcy after the devastating effects of Hurricane Sandy, MetroStar Home Health Products, a privately owned Home Health Products company located at http://www.MetroStarDME.com , will be collecting new, unwrapped toys to distribute to children throughout those areas most impacted by Hurri...

Global Healthcare, Regulatory and Reimbursement Landscape Forecasts and Trends in UAE, Canada and Taiwan

November 26, 2012 1:55 pm | by Bio-Medicine.Org | Comments

FARMINGTON, Conn., Nov. 26, 2012 /PRNewswire-iReach/ -- The healthcare system in the United Arab Emirates is characterized by high public expenditure on implementation of healthcare policies and expanding private infrastructure to offer more sophisticated facilities. Taiwan's healthcare system is characterized by three positive trends: a growing elderly population, universal healthcare insurance...

Research and Markets: Future Horizons in the European Hematology and Flow Cytometry Markets

November 26, 2012 1:44 pm | by The Associated Press | Comments

DUBLIN--(BUSINESS WIRE)--Nov 26, 2012--Research and Markets ( http://www.researchandmarkets.com/research/rldd9x/future_horizons ) has announced the addition of the "Future Horizons in the European Hematology and Flow Cytometry Markets - France, Germany, Italy, Spain, UK: Supplier Shares and Sales...

Easy on the Stomach: ALCAT Worldwide Sponsors Successful Conference on Gut, Brain & Autoimmune Disorders

November 26, 2012 1:13 pm | by Bio-Medicine.Org | Comments

DEERFIELD BEACH, Fla., Nov. 26, 2012 /- Recently the American Academy of Anti-Aging Medicine (A4M) hosted the successful conference in Fort Lauderdale called Gut, Brain, and Autoimmune Disorders: The Role of Food .  Sponsored by ALCAT Worldwide, the two day conference was well received by the attendees and impressive list of speakers.  ALCAT Worldwide is a divisio...

Report: Baxter's in the hunt for $4B Gambro buyout | Wall Street Beat

November 26, 2012 12:15 pm | by Mass Device | Comments

Baxter International is said to be in the hunt for a $4 billion acquisition of Swedish medical device company Gambro. Anonymous sources say that Baxter (NYSE:BAX) is pursuing an acquisition of Swedish medical device company Gambro for $4 billion...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading